ARTELO BIOSCIENCES, INC. Quarterly General and Administrative Expense in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
Artelo Biosciences, Inc. quarterly/annual General and Administrative Expense history and growth rate from Q1 2014 to Q2 2024.
  • Artelo Biosciences, Inc. General and Administrative Expense for the quarter ending June 30, 2024 was $827K, a 19.9% decline year-over-year.
  • Artelo Biosciences, Inc. General and Administrative Expense for the twelve months ending June 30, 2024 was $4.05M, a 21.4% decline year-over-year.
  • Artelo Biosciences, Inc. annual General and Administrative Expense for 2023 was $4.23M, a 29% decline from 2022.
  • Artelo Biosciences, Inc. annual General and Administrative Expense for 2022 was $5.96M, a 5.86% increase from 2021.
  • Artelo Biosciences, Inc. annual General and Administrative Expense for 2021 was $5.63M, a 104% increase from 2020.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $4.05M $827K -$205K -19.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $4.26M $1.08M +$25K +2.37% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $4.23M $1.12M -$634K -36.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 $4.87M $1.03M -$287K -21.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $5.16M $1.03M -$383K -27.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $5.54M $1.06M -$425K -28.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $5.96M $1.75M -$348K -16.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 $6.31M $1.32M +$105K +8.67% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $6.21M $1.42M +$131K +10.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $6.08M $1.48M +$93K +6.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $5.98M $2.1M +$1.03M +96.6% Sep 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $4.95M $1.21M -$330K -21.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $5.28M $1.28M +$895K +230% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $4.39M $1.39M +$955K +220% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $3.43M $1.07M +$664K +165% Sep 1, 2020 Dec 31, 2020 10-KT 2022-03-21
Q3 2020 $2.77M $1.54M +$1.25M +439% Jun 1, 2020 Aug 31, 2020 10-KT 2022-03-21
Q2 2020 $1.51M $389K -$13.6K -3.38% Mar 1, 2020 May 31, 2020 10-Q 2021-07-12
Q1 2020 $1.53M $434K +$376K +649% Dec 1, 2019 Feb 29, 2020 10-Q 2021-04-13
Q4 2019 $1.15M $403K +$198K +96.2% Sep 1, 2019 Nov 30, 2019 10-Q 2021-01-14
Q3 2019 $952K $286K +$49.9K +21.1% Jun 1, 2019 Aug 31, 2019 10-K 2020-11-04
Q2 2019 $902K $403K +$298K +285% Mar 1, 2019 May 31, 2019 10-Q 2020-07-13
Q1 2019 $604K $57.9K +$27K +87.3% Dec 1, 2018 Feb 28, 2019 10-Q 2020-04-13
Q4 2018 $577K $206K +$68.9K +50.5% Sep 1, 2018 Nov 30, 2018 10-Q 2020-01-14
Q3 2018 $508K $236K +$149K +170% Jun 1, 2018 Aug 31, 2018 10-K/A 2019-12-18
Q2 2018 $360K $105K +$85.3K +442% Mar 1, 2018 May 31, 2018 10-Q 2019-07-15
Q1 2018 $274K $30.9K +$27.1K +713% Dec 1, 2017 Feb 28, 2018 10-Q 2019-04-15
Q4 2017 $247K $137K +$136K Sep 1, 2017 Nov 30, 2017 10-Q 2019-01-14
Q3 2017 $111K $87.5K Jun 1, 2017 Aug 31, 2017 10-K 2018-11-29
Q2 2017 $19.3K Mar 1, 2017 May 31, 2017 10-Q 2018-07-13
Q1 2017 $3.8K Dec 1, 2016 Feb 28, 2017 10-Q/A 2018-05-14
Q4 2016 $313* -$296 Sep 1, 2016 Nov 30, 2016 10-Q/A 2018-03-21
Q4 2015 $609* Sep 1, 2015 Nov 30, 2015 10-Q 2017-01-10
Q2 2014 $3.65K Mar 1, 2014 May 31, 2014 10-Q 2015-07-15
Q1 2014 $95.00* Nov 29, 2013 Feb 28, 2014 10-Q 2015-04-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.